The Immune Response in In Situ Tissue Engineering of Aortic Heart Valves

Published: Jun 12, 2013
Abstract
The gold standard for treatment of advanced heart valve disease is surgical heart valve re‐ placement. None of the currently available mechanical and bioprosthetic heart valve substi‐ tutes resembles normal heart valve function. While mechanical heart valves offer excellent durability, they require life-long anticoagulation to control thromboembolism, which inher‐ ently leads to an increased risk of hemorrhage complications. Bioprosthetic valves...
Paper Details
Title
The Immune Response in In Situ Tissue Engineering of Aortic Heart Valves
Published Date
Jun 12, 2013
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.